524 related articles for article (PubMed ID: 23666603)
21. Predictors of success with methotrexate treatment of tubal ectopic pregnancy at Grady Memorial Hospital.
Potter MB; Lepine LA; Jamieson DJ
Am J Obstet Gynecol; 2003 May; 188(5):1192-4. PubMed ID: 12748475
[TBL] [Abstract][Full Text] [Related]
22. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
23. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy.
Yıldız A; Bilge O
Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015
[TBL] [Abstract][Full Text] [Related]
24. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
[TBL] [Abstract][Full Text] [Related]
25. Outcome, complications and future fertility in women treated with uterine artery embolization and methotrexate for non-tubal ectopic pregnancy.
Krissi H; Hiersch L; Stolovitch N; Nitke S; Wiznitzer A; Peled Y
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():172-6. PubMed ID: 25300059
[TBL] [Abstract][Full Text] [Related]
26. Expectant management of tubal pregnancies with human chorionic gonadotropin up to 2000 mIU/mL.
Kugelman N; Cohen B; Yossef F; Margieh N; Regev N; Shani U; Bart Y
Int J Gynaecol Obstet; 2024 Mar; 164(3):1094-1100. PubMed ID: 37776069
[TBL] [Abstract][Full Text] [Related]
27. Trichosanthin, a Chinese medicine for the medical treatment of ectopic pregnancy with high levels of β-hCG.
Xiang DJ; Chen LM; Gu JS; Stone P; Chen Q
Reprod Sci; 2012 May; 19(5):534-8. PubMed ID: 22267541
[TBL] [Abstract][Full Text] [Related]
28. βhCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: is the Day 4 βhCG necessary? A retrospective cohort study.
Atkinson M; Gupta S; Mcgee T
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):475-9. PubMed ID: 25287565
[TBL] [Abstract][Full Text] [Related]
29. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels.
Shatkin Hamish N; Wolf M; Tendler R; Sharon A; Bornstein J; Odeh M
J Obstet Gynaecol Res; 2020 Jul; 46(7):1104-1109. PubMed ID: 32406562
[TBL] [Abstract][Full Text] [Related]
30. ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study.
Orozco EM; Sánchez-Durán MA; Bello-Muñoz JC; Sagalá J; Carreras E; Roura LC
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):695-9. PubMed ID: 24871360
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Tubal Pregnancy After Treatment With Methotrexate by Ultrasound Elastography.
Xie M; Zhang X; Wang W; Hua K
J Ultrasound Med; 2018 Feb; 37(2):417-422. PubMed ID: 28850688
[TBL] [Abstract][Full Text] [Related]
32. [Drug treatment of tubal pregnancy with methotrexate, with an analysis of 5 cases].
Dimitrova E; Milchev N; Krumov G; Paskaleva V; Velchev G
Akush Ginekol (Sofiia); 2002; 41(2):28-9. PubMed ID: 12066547
[TBL] [Abstract][Full Text] [Related]
33. [Medical treatment of unruptured ectopic pregnancy].
Rojas Mora E; Hernández Vivar LE; Sánchez Contreras J; Risco Cortés RJ; Pulido Olivares VH
Ginecol Obstet Mex; 2004 Apr; 72():135-41. PubMed ID: 15318753
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.
Kovaleva A; Irishina N; Pereira A; Cuesta-Guardiola T; Ortiz-Quintana L
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():35-38. PubMed ID: 27936449
[TBL] [Abstract][Full Text] [Related]
35. Treatment of ectopic pregnancy with methotrexate.
Kasum M; Oresković S; Simunić V; Jezek D; Tomić V; Tomić J; Gall V; Mihaljević S
Acta Clin Croat; 2012 Dec; 51(4):543-8. PubMed ID: 23540161
[TBL] [Abstract][Full Text] [Related]
36. Morbid obesity and outcome of ectopic pregnancy following capped single-dose regimen methotrexate.
Hoyos LR; Malik M; Najjar M; Rodriguez-Kovacs J; Abdallah M; Vilchez G; Awonuga AO
Arch Gynecol Obstet; 2017 Feb; 295(2):375-381. PubMed ID: 27844211
[TBL] [Abstract][Full Text] [Related]
37. The role of early determination of β-human chorionic gonadotropin levels in predicting the success of single-dose methotrexate treatment in ectopic pregnancy.
Çelik H; Tosun M; Işık Y; Avcı B
Ginekol Pol; 2016; 87(7):484-7. PubMed ID: 27504939
[TBL] [Abstract][Full Text] [Related]
38. Predictors of failure of the commonly used single-dose methotrexate protocol for treating tubal ectopic pregnancies.
Ozyurek ES; Akmut E; Kaya E; Akca A; Akbayır O
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):755-760. PubMed ID: 29241915
[TBL] [Abstract][Full Text] [Related]
39. A new predictive scoring system including shock index for unruptured tubal pregnancy patients.
Kahyaoglu S; Turgay I; Gocmen M; Sut N; Batioglu S
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):99-103. PubMed ID: 16246482
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate treatment in progressive tubal ectopic pregnancies and hCG-related clinicosurgical implications.
Dogan A; Gulhan I; Uyar I; Ekin A; Gezer C; Bilgin M; Taner CE; Ertas IE
Kaohsiung J Med Sci; 2016 Jun; 32(6):317-22. PubMed ID: 27377845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
